EXACT Therapeutics AS

OB:EXTX Stock Report

Market Cap: NOK 42.4m

EXACT Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EXTX?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms4,291,3166.78%
General Public7,685,32512.1%
Institutions8,546,78113.5%
Individual Insiders10,689,88116.9%
Private Companies14,541,87323%
Public Companies17,508,17127.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.81% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.3%
GE HealthCare Technologies Inc.
16,647,956NOK 11.2m0%no data
9.65%
Investinor Direkte AS
6,105,522NOK 4.1m0%no data
6.78%
Canica As
4,291,316NOK 2.9m0%0.01%
4.78%
Svein Kvåle
3,024,270NOK 2.0m0%no data
4.74%
Brekke Holding As
3,000,000NOK 2.0m0%no data
4.27%
Masha Paule Nathalie Stromme
2,699,842NOK 1.8m0%no data
4.25%
Helene Sundt AS
2,688,291NOK 1.8m0%no data
3.36%
Andrew Healey
2,123,885NOK 1.4m0%no data
2.88%
Per Sontum
1,824,595NOK 1.2m0%no data
2.76%
Optimuspistor As
1,745,464NOK 1.2m0%no data
1.99%
The Goldman Sachs Group, Inc.
1,255,956NOK 841.5k0%no data
1.97%
JPMorgan Chase & Co.
1,244,999NOK 834.1k0%no data
1.84%
Kvantia AS
1,165,568NOK 780.9k0%0.07%
1.6%
DNB Asset Management AS
1,010,799NOK 677.2k0%no data
1.59%
T.D. VEEN AS
1,004,741NOK 673.2k0%0.1%
1.41%
CGS Holding AS
890,500NOK 596.6k0%no data
1.36%
Norda ASA
860,215NOK 576.3k0%no data
1.15%
P53 Invest AS
726,500NOK 486.8k0%100.0%
1.14%
Danske Bank A/S
719,109NOK 481.8k0%no data
1.14%
Danske Invest Asset Management AS
719,109NOK 481.8k0%no data
1.11%
Blueberry Capital As
700,000NOK 469.0k0%100.0%
0.9%
Jonathan Allis
569,370NOK 381.5k0%no data
0.55%
William Castell
346,664NOK 232.3k0%no data
0.18%
Basen Capital As
112,096NOK 75.1k0%no data
0.12%
Anders Wold
72,924NOK 48.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/30 04:05
End of Day Share Price 2026/07/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EXACT Therapeutics AS is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.